Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barker

Showing results (881-890 of 903) with videos related to

Pageof 91
Sort By:
Elife|July 1, 2015
The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictusMoritz U G Kraemer, Marianne E Sinka, Kirsten A Duda, et al.
Plos One|February 2, 2023
Quantifying heterogeneities in arbovirus transmission: Description of the rationale and methodology for a prospective longitudinal study of dengue and Zika virus transmission in Iquitos, Peru (2014-2019)Amy C Morrison, Valerie A Paz-Soldan, Gonzalo M Vazquez-Prokopec, et al.
Journal of Medicinal Chemistry|September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Genome Research|September 1, 2009
Comparative genomic analyses of the human fungal pathogens Coccidioides and their relativesThomas J Sharpton, Jason E Stajich, Steven D Rounsley, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2022
Efficacy of a spatial repellent for control of <i>Aedes</i>-borne virus transmission: A cluster-randomized trial in Iquitos, PeruAmy C Morrison, Robert C Reiner, William H Elson, et al.
Genome Research|June 3, 2010
Population genomic sequencing of Coccidioides fungi reveals recent hybridization and transposon controlDaniel E Neafsey, Bridget M Barker, Thomas J Sharpton, et al.
BMJ Mental Health|June 8, 2023
New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosisAndrea Cipriani, Soraya Seedat, Lea Milligan, et al.
Nature Communications|September 26, 2024
Mental illness and COVID-19 vaccination: a multinational investigation of observational & register-based dataMary M Barker, Kadri Kõiv, Ingibjörg Magnúsdóttir, et al.
Pageof 91

Showing results (881-890 of 903) with videos related to

Sort By:
Pageof 91
Elife|July 1, 2015
The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictusMoritz U G Kraemer, Marianne E Sinka, Kirsten A Duda, et al.
Plos One|February 2, 2023
Quantifying heterogeneities in arbovirus transmission: Description of the rationale and methodology for a prospective longitudinal study of dengue and Zika virus transmission in Iquitos, Peru (2014-2019)Amy C Morrison, Valerie A Paz-Soldan, Gonzalo M Vazquez-Prokopec, et al.
Journal of Medicinal Chemistry|September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Genome Research|September 1, 2009
Comparative genomic analyses of the human fungal pathogens Coccidioides and their relativesThomas J Sharpton, Jason E Stajich, Steven D Rounsley, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2022
Efficacy of a spatial repellent for control of <i>Aedes</i>-borne virus transmission: A cluster-randomized trial in Iquitos, PeruAmy C Morrison, Robert C Reiner, William H Elson, et al.
Genome Research|June 3, 2010
Population genomic sequencing of Coccidioides fungi reveals recent hybridization and transposon controlDaniel E Neafsey, Bridget M Barker, Thomas J Sharpton, et al.
BMJ Mental Health|June 8, 2023
New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosisAndrea Cipriani, Soraya Seedat, Lea Milligan, et al.
Nature Communications|September 26, 2024
Mental illness and COVID-19 vaccination: a multinational investigation of observational & register-based dataMary M Barker, Kadri Kõiv, Ingibjörg Magnúsdóttir, et al.
Pageof 91